Loading...
XCSE
MONSO
Market cap1mUSD
Dec 05, Last price  
0.19DKK
1D
-0.52%
1Q
-22.36%
IPO
-97.06%
Name

Monsenso A/S

Chart & Performance

D1W1MN
XCSE:MONSO chart
P/E
P/S
1.14
EPS
Div Yield, %
Shrs. gr., 5y
34.42%
Rev. gr., 5y
4.92%
Revenues
11m
+16.01%
1,298,1015,247,6076,423,0007,503,0008,780,0009,063,0007,143,0006,213,0009,624,00011,165,000
Net income
-6m
L+12.02%
-1,186,760-2,662,121-3,361,000-2,087,00024,000-4,713,000-8,153,000-7,854,000-5,357,000-6,001,000
CFO
-7m
L
000-2,499,000-210,0002,906,000-4,383,000-3,390,0002,552,000-7,033,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, and psychoeducation and cognitive behavioral therapy; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company also provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, messaging, shared decision-making, and notes/medical record keeping; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment. It serves patients, clinicians, healthcare systems and researchers, and carers. Monsenso A/S was incorporated in 2013 and is based in Copenhagen, Denmark.
IPO date
Jun 10, 2020
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT